Shanghai Fosun Pharmaceutical (Group) Co <2196.HK> will sign a definitive agreement on Wednesday to buy a controlling stake in India's Gland Pharma in a $1.4 billion deal, the Economic Times newspaper reported, citing a source with direct knowledge.
In May, Shanghai Fosun had made a non-binding proposal to buy Gland Pharma, which is backed by KKR & Co <KKR.N>, to boost its drug manufacturing and research and development capacity.
Fosun did not immediately comment, when contacted by Reuters. Gland Pharma made no immediate comment on the report.
For More Information Stock advisory company indore,Share Market Tips,stock advisory tips,best stock advisory company in indore,Nifty Future Tips,currency Tips,Stock Option Tips, Future&Option Tips,stock cash tips,Nifty Option Tips,Bullion tips And call us :-9827808090.
In May, Shanghai Fosun had made a non-binding proposal to buy Gland Pharma, which is backed by KKR & Co <KKR.N>, to boost its drug manufacturing and research and development capacity. 
No comments:
Post a Comment